Last reviewed · How we verify
NCT04242550: BEAM
Binge Eating Anxiety and Mood
NA trial testing Executive Function- Enhanced CBT for BED (EF-BED+CBT) in Binge-Eating Disorder in 39 participants. Completed in 24 November 2021.
24 November 2021
Quick facts
| Lead sponsor | University of California, San Diego |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 39 |
| Start date | 23 June 2020 |
| Primary completion | 24 November 2021 |
| Estimated completion | 24 November 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Executive Function- Enhanced CBT for BED (EF-BED+CBT)
- Cognitive Behavioral Therapy (CBT)
Conditions studied
- Binge-Eating Disorder — all drugs for Binge-Eating Disorder →
- Binge Eating — all drugs for Binge Eating →
- Anxiety Disorders — all drugs for Anxiety Disorders →
- Mood Disorders — all drugs for Mood Disorders →
Sponsor
University of California, San Diego
Who can join
Adults 18 to 65, any sex, with Binge-Eating Disorder or Binge Eating. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Binge Eating Disorder (BED) is the most common eating disorder, and currently, the best behavioral treatments only work for 40-60% of adults. BED often co-occurs with mood and anxiety disorders, and both are associated with neurocognitive deficits related to executive function (EF). These EF deficits contribute to worsening BED symptoms and make it difficult for these adults to adhere to treatment recommendations. The proposed study aims to develop an EF training enhanced behavioral treatment for BED and compare its effectiveness to the standard cognitive behavioral therapy for patients with BED and a co-occurring mood or anxiety disorder.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Adding executive function training to cognitive behavioral therapy for binge eating disorder: A pilot randomized controlled trial.
Eichen DM, Strong DR, Twamley EW, Boutelle KN. · · 2023 · cited 6× · PMID 37660487 · DOI 10.1016/j.eatbeh.2023.101806
Verify or expand the search:
- PubMed search for NCT04242550
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Binge-Eating Disorder
Currently open trials in the same condition.
- NCT07060534 — Building Healthy Eating and Self-Esteem Together for University Students · NA · recruiting
- NCT07237607 — Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders · NA · recruiting
- NCT06864065 — Study of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder · NA · recruiting
- NCT06819813 — Project VIBE: Virtual Intervention for Binge Eating in Adolescents · NA · recruiting
- NCT06485687 — Low Intensity Focused Ultrasound for Binge Eating Disorder · NA · active not recruiting
Other University of California, San Diego trials
Trials by the same sponsor.
- NCT07342543 — Guided Physical Activity Counseling for Hypertension in Primary Care · NA · not yet recruiting
- NCT06505317 — Artificial Intelligence for Early Detection of Peripheral Artery Disease · NA · not yet recruiting
- NCT07211802 — CKM For Safe Use of SGLT2i in Type 1 Diabetes · Phase 3 · not yet recruiting
- NCT07524751 — Culturally Adapted Pain Management for Indigenous Peoples · NA · not yet recruiting
- NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04242550 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Diego
- Last refreshed: 6 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04242550.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing